SEC Form 4 · accession 0001479791-18-000007
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Jan 19, 2018
Accepted (ET)
Jan 23, 2018 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Jan 19, 2018 | S | 3,000 | $0.125 | D | 25,559,618 | D | |
| INVO Bioscience Common Stock | Jan 22, 2018 | S | 10,000 | $0.116 | D | 25,549,618 | D | |
| INVO Bioscience Common Stock | Jan 22, 2018 | S | 20,000 | $0.117 | D | 25,529,618 | D | |
| INVO Bioscience Common Stock | Jan 22, 2018 | S | 13,500 | $0.1195 | D | 25,516,118 | D |
Table II — derivative securities
No Table II lines on this filing.